Table 2.

Clinical and laboratory characteristics of patients stratified by CONUT score

Variable	CONUT score = 0 (N = 204)	CONUT score = 1–2 (N = 175)	CONUT score ≥3 (N = 98)	p value
Age	58.0±16.7	58.5±18.8	67.6±16.5	<0.001b, c
Male, %	35.3	49.1	46.7	0.117
Hypertension, %	47.3	52.9	74.2	<0.001
Diabetes mellitus, %	19.4	23.3	28.1	0.252
CAD, %	14.4	29.1	38.2	<0.001
Smoking, %	20.9	24.4	11.2	0.042
BMI, kg/m2	24.6±3.3	24.6±2.3	23.4±1.3	0.030b, c
LVEF, %	62.4±5.3	61.4±5.9	59.1±7.7	0.002b, c
Beta blocker, %	31.3	38.4	40.4	0.215
Nondihydropyridine calcium channel blockers, %	2.5	4.1	5.6	0.402
Statin, %	11.9	22.1	28.1	<0.001
PNI	41.0±3.2	39.3±4.1	32.5±4.4	<0.001a, b, c
Serum albumin, g/dL	4.03±0.42	3.91±0.42	3.1±0.53	<0.001a, b, c
Total cholesterol, mg/dL	225.2±34.7	176.6±41.9	167.5±44.0	<0.001a, b
LDL cholesterol, mg/dL	146.3±32.2	106.7±35.2	103.9±32.2	<0.001a, b
HDL cholesterol, mg/dL	51.9±15.8	49.2±14.2	45.7±13.9	0.006b
Triglyceride, mg/dL	160.9±90.3	126.6±66.6	123.5±50.3	<0.001a, b
Creatinine, mg/dL	0.92±0.6	1.04±0.74	1.29±0.9	0.007a, b
White blood cell count, ×109/L	7.45±2.5	7.76±2.3	8.19±4.2	0.685
Hemoglobin, g/dL	14.0±1.5	14.4±6.5	12.7±3.1	<0.001b, c
Lymphocyte count	2.42±0.7	2.03±0.7	1.52±0.7	<0.001a, b, c
Heart rate (mean±SD), bpm	76.99±7.11	76.45±7.42	77.84±6.35	0.379
PACs, mean ± SD, n	638.2±2,322.6	1,075.2±2,944.8	1,562.6±4,080.7	<0.001a, b
Median (interquartile range)	17 (127)	37 (377)	108 (1,012)	<0.001b, c
PVCs, mean ± SD, n	1,422.2±5,055.8	1,826.0±4,814.9	1,802.5±3,813.9
Median (interquartile range)	1 (276)	11 (728)	179.5 (1,963)	<0.001b, c
PVC burden, mean ± SD, %	1.43±4.8	1.84±4.6	1.97±4.2
Median (interquartile range)	0 (0.48)	0.01 (1)	1 (2.1)
NSVT, %	3.5	8.4	12.3	0.158
PAF, %	8.4	6.6	20.7	<0.001
SVT, %	21.8	23.4	34.6	0.070

Abbreviations as in Table 1. Significant differences were found between

^aCONUT score = 0 versus CONUT score = 1–2,

^bCONUT score = 0 versus CONUT score ≥3, and

^cCONUT score = 1–2 versus CONUT score ≥3.